DepoMed Demonstrates The Risks Of Small Biotech [View article]
More than other sectors, investments in Biotech are reckless unless you have an understanding of the product. In fact, casual investors in Biotech stocks maybe actually be experiencing drug related side effects from their investments. For an interesting viewpoint:
DepoMed Demonstrates The Risks Of Small Biotech [View article]
mnrtrading.blogspot.co...